Contact us
  • Home
  • Resource
  • How Can Life Science Companies benefit from Digital Health in Oncology?

How Can Life Science Companies benefit from Digital Health in Oncology?

A diagnosis of cancer is a period filled with immense stress and uncertainty. Patients are thrust into a treatment journey filled with numerous medical interventions, a continuously changing treatment strategy, and unforeseen complications. Furthermore, patients grapple with uncertainties surrounding the logistics of their care, including location, timing, and financial implications.

The frequency of such scenarios is on the rise. Digital health innovations play a pivotal role in aiding patients to navigate the intricate landscape of cancer treatment. Digital health solutions are designed to complement pharmaceutical interventions and medical equipment, offering patients access to interventions and recommendations grounded in scientific evidence. In this article, Sophie Opdyke, Merck’s Senior Vice President of Global Marketing Oncology, shared insights on how digital health technologies are poised to empower pharmaceutical and healthcare provider organizations to enhance the patient experience amidst the challenging journey of cancer treatment.

Fill out the form to access this content:

"*" indicates required fields

I consent that my personal data is stored and processed as described in theprivacy policy.*

This field is for validation purposes and should be left unchanged.

*to process your contact request. If you do not fill them in, your request cannot be processed. To find out more about the use of your personal data and how to exercise your rights, please consult the Privacy Policy

Back to top
Follow us: subscribe